Cantor Fitzgerald Has Lowered Expectations for Nano-X Imaging (NASDAQ:NNOX) Stock Price

Nano-X Imaging (NASDAQ:NNOX) had its price objective cut by Cantor Fitzgerald from $12.00 to $9.00 in a report released on Tuesday morning,Benzinga reports. They currently have an overweight rating on the stock.

Separately, D. Boral Capital restated a “buy” rating and set a $15.00 target price on shares of Nano-X Imaging in a research report on Monday.

Nano-X Imaging Trading Down 3.2 %

Shares of NNOX stock opened at $4.83 on Tuesday. Nano-X Imaging has a twelve month low of $4.61 and a twelve month high of $11.39. The stock has a market cap of $279.07 million, a P/E ratio of -5.68 and a beta of 1.99. The stock has a 50 day moving average of $6.48 and a 200 day moving average of $6.63.

Nano-X Imaging (NASDAQ:NNOX) last posted its earnings results on Monday, March 31st. The company reported ($0.23) earnings per share for the quarter, missing the consensus estimate of ($0.15) by ($0.08). Nano-X Imaging had a negative net margin of 465.38% and a negative return on equity of 27.63%. The firm had revenue of $3.00 million for the quarter, compared to analysts’ expectations of $3.80 million. On average, research analysts predict that Nano-X Imaging will post -0.92 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently made changes to their positions in the business. PharVision Advisers LLC purchased a new stake in Nano-X Imaging in the 4th quarter worth $80,000. ProShare Advisors LLC grew its position in shares of Nano-X Imaging by 50.9% in the fourth quarter. ProShare Advisors LLC now owns 15,464 shares of the company’s stock valued at $111,000 after purchasing an additional 5,216 shares during the period. Deutsche Bank AG raised its position in shares of Nano-X Imaging by 38.6% during the 4th quarter. Deutsche Bank AG now owns 52,499 shares of the company’s stock worth $378,000 after purchasing an additional 14,617 shares during the last quarter. Cetera Investment Advisers lifted its stake in Nano-X Imaging by 132.2% in the 4th quarter. Cetera Investment Advisers now owns 32,441 shares of the company’s stock valued at $234,000 after buying an additional 18,469 shares in the last quarter. Finally, Bayesian Capital Management LP acquired a new stake in Nano-X Imaging in the 4th quarter worth about $81,000. Hedge funds and other institutional investors own 21.49% of the company’s stock.

About Nano-X Imaging

Nano-X Imaging Ltd. develops a commercial-grade tomographic imaging device with a digital X-ray source. The company provides teleradiology services and develops artificial intelligence applications to be used in real-world medical imaging applications. Its X-ray source is based on a digital micro-electro-mechanical systems semiconductor cathode.